preprint · bioRxiv (Cold Spring Harbor Laboratory)
Epilepsy is a neurological condition characterised by recurrent seizures, but the specific roles played by microRNAs in the condition remain poorly defined. To explore these mechanisms and identify potential biomarkers, researchers evaluated RNA and microRNA sequencing datasets drawn from six existing studies. The data covered brain tissue as well as plasma small extracellular vesicles collected from individuals with epilepsy. By analysing differential gene expression, the investigation uncovered distinct genetic targets and their regulatory microRNAs. In particular, the genes SIX4 and KCTD7 showed reduced expression in epileptogenic brain regions relative to irritative zones. Furthermore, CABP1, SLC20A1, and SLC35G1 were under-expressed in brain tissues, paired with specific regulatory microRNAs including hsa-miR-27a-3p, hsa-let-7b-5p, hsa-miR-15a-5p, and hsa-miR-195-5p. These molecular links point towards candidate pathways for understanding and managing epilepsy.
Epilepsy affects millions of individuals worldwide, yet tracking and treating the condition remains challenging. Pinpointing specific microRNAs and their related genes clarifies the underlying biology of the disease. This molecular insight can support the discovery of new diagnostic indicators and guide the design of targeted treatments for managing seizure disorders.
This research provides preliminary target discovery data that could inform diagnostic biomarker panels or therapeutic drug targets for epilepsy. Potential end users include diagnostic developers and pharmaceutical companies working on neurological therapies. Because the findings stem from computational re-analysis of existing public datasets, the work represents very early-stage discovery that requires experimental and clinical validation before commercialisation.
AI-generated from the published abstract. Always read the original work before citing.
Abstract Epilepsy is a neurological disease defined by episodes of synchronous convulsions. Recently, miRNAs have been proven as promising biomarkers for multiple ailments like tumors and neurodegenerative disorders; their role in epilepsy is still unclear. This study aimed to understand the involvement of miRNAs in the disease and to detect the potential biomarkers for the treatment of epilepsy. RNA transcripts, and miRNA from brain tissue and plasma small extracellular vesicle samples of epileptogenic patients from 6 different studies downloaded from the NCBI sequence read archive (SRA) were analyzed with particular interest in genes that might be involved in epilepsy. Alignment of transcripts to hg38 was done using HISAT2 and the raw counts were generated using HTseq-count. miRNA genes were identified using miRDeep2. EdgeR and GEO2 were used to identify DEGs for both mRNA and miRNA datasets. Finally, TargetScan web tool was used to predict potentially significantly expressed mRNA target genes using the identified miRNA genes. Analysis of these datasets revealed target genes in epilepsy and their associated miRNAs. SIX4 and KCTD7 were under-expressed in epileptogenic zones of the brain compared to the irritative zone. CABP1, SLC20A1 and SLC35G1 were under-expressed in brain tissues. Hsa-miR-27a-3p was identified as a regulator of CABP1 expression, hsa-let-7b-5p regulates SLC20A1 while hsa-miR-15a-5p and hsa-miR-195-5p are regulators for SLC35G1. These observations highlight the importance of miRNAs as novel biomarkers of epilepsy. Understanding and controlling these regulatory interactions may help to define potential therapies for epilepsy. This would also help to better understand miRNA-mediated gene regulation in epilepsy.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1101/2023.09.11.557132
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
